Trials / Completed
CompletedNCT02954341
CardioMEMS HF System OUS Post Market Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 321 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this Post Market Study (PMS) is to evaluate the use of the CardioMEMS HF System in patients with New York Heart Association (NYHA) Class III Heart Failure in a commercial setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CardioMEMS HF System |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2023-12-08
- Completion
- 2023-12-08
- First posted
- 2016-11-03
- Last updated
- 2025-02-24
- Results posted
- 2025-02-24
Locations
5 sites across 5 countries: Australia, Belgium, Denmark, France, United Kingdom
Source: ClinicalTrials.gov record NCT02954341. Inclusion in this directory is not an endorsement.